CN116478857B - Bifidobacterium longum variant capable of producing polysaccharide and application of polysaccharide in crystal ball probiotic preparation - Google Patents
Bifidobacterium longum variant capable of producing polysaccharide and application of polysaccharide in crystal ball probiotic preparation Download PDFInfo
- Publication number
- CN116478857B CN116478857B CN202310094263.2A CN202310094263A CN116478857B CN 116478857 B CN116478857 B CN 116478857B CN 202310094263 A CN202310094263 A CN 202310094263A CN 116478857 B CN116478857 B CN 116478857B
- Authority
- CN
- China
- Prior art keywords
- coating
- bifidobacterium longum
- polysaccharide
- probiotic
- layer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 241001608472 Bifidobacterium longum Species 0.000 title claims abstract description 64
- 229940009291 bifidobacterium longum Drugs 0.000 title claims abstract description 64
- 229920001282 polysaccharide Polymers 0.000 title claims abstract description 63
- 239000005017 polysaccharide Substances 0.000 title claims abstract description 63
- 150000004676 glycans Chemical class 0.000 title claims abstract description 62
- 239000006041 probiotic Substances 0.000 title claims description 79
- 235000018291 probiotics Nutrition 0.000 title claims description 79
- 230000000529 probiotic effect Effects 0.000 title claims description 56
- 238000002360 preparation method Methods 0.000 title claims description 45
- 239000013078 crystal Substances 0.000 title claims description 40
- 238000000576 coating method Methods 0.000 claims description 137
- 239000011248 coating agent Substances 0.000 claims description 133
- 239000010410 layer Substances 0.000 claims description 83
- 239000000463 material Substances 0.000 claims description 54
- 239000008188 pellet Substances 0.000 claims description 34
- 239000000203 mixture Substances 0.000 claims description 27
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 26
- 239000004519 grease Substances 0.000 claims description 20
- 238000007873 sieving Methods 0.000 claims description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 20
- 239000004373 Pullulan Substances 0.000 claims description 16
- 229920001218 Pullulan Polymers 0.000 claims description 16
- 238000000034 method Methods 0.000 claims description 14
- 238000009505 enteric coating Methods 0.000 claims description 13
- 239000002702 enteric coating Substances 0.000 claims description 13
- 235000019423 pullulan Nutrition 0.000 claims description 12
- 239000011247 coating layer Substances 0.000 claims description 11
- 238000002955 isolation Methods 0.000 claims description 11
- 239000007787 solid Substances 0.000 claims description 8
- 235000019482 Palm oil Nutrition 0.000 claims description 6
- 235000021323 fish oil Nutrition 0.000 claims description 6
- 239000002540 palm oil Substances 0.000 claims description 6
- 235000019441 ethanol Nutrition 0.000 claims description 5
- 238000001125 extrusion Methods 0.000 claims description 5
- 238000009472 formulation Methods 0.000 claims description 5
- 239000001814 pectin Substances 0.000 claims description 5
- 235000010987 pectin Nutrition 0.000 claims description 5
- 229920001277 pectin Polymers 0.000 claims description 5
- 238000005563 spheronization Methods 0.000 claims description 5
- 239000000843 powder Substances 0.000 claims description 4
- 229920002472 Starch Polymers 0.000 claims description 3
- 229920002494 Zein Polymers 0.000 claims description 3
- 239000013535 sea water Substances 0.000 claims description 3
- 235000019698 starch Nutrition 0.000 claims description 3
- 239000005019 zein Substances 0.000 claims description 3
- 229940093612 zein Drugs 0.000 claims description 3
- 229920001817 Agar Polymers 0.000 claims description 2
- 239000008272 agar Substances 0.000 claims description 2
- 235000010419 agar Nutrition 0.000 claims description 2
- 235000010980 cellulose Nutrition 0.000 claims 3
- 229920002678 cellulose Polymers 0.000 claims 3
- 229920000591 gum Polymers 0.000 claims 3
- 239000004925 Acrylic resin Substances 0.000 claims 2
- 229920000178 Acrylic resin Polymers 0.000 claims 2
- 108010022355 Fibroins Proteins 0.000 claims 2
- 108010010803 Gelatin Proteins 0.000 claims 2
- 241001465754 Metazoa Species 0.000 claims 2
- 239000004372 Polyvinyl alcohol Substances 0.000 claims 2
- 229920001800 Shellac Polymers 0.000 claims 2
- 150000001298 alcohols Chemical class 0.000 claims 2
- 230000004888 barrier function Effects 0.000 claims 2
- 239000001913 cellulose Substances 0.000 claims 2
- 239000000084 colloidal system Substances 0.000 claims 2
- 239000008273 gelatin Substances 0.000 claims 2
- 229920000159 gelatin Polymers 0.000 claims 2
- 235000019322 gelatine Nutrition 0.000 claims 2
- 235000011852 gelatine desserts Nutrition 0.000 claims 2
- 229920002451 polyvinyl alcohol Polymers 0.000 claims 2
- 239000004208 shellac Substances 0.000 claims 2
- ZLGIYFNHBLSMPS-ATJNOEHPSA-N shellac Chemical compound OCCCCCC(O)C(O)CCCCCCCC(O)=O.C1C23[C@H](C(O)=O)CCC2[C@](C)(CO)[C@@H]1C(C(O)=O)=C[C@@H]3O ZLGIYFNHBLSMPS-ATJNOEHPSA-N 0.000 claims 2
- 229940113147 shellac Drugs 0.000 claims 2
- 235000013874 shellac Nutrition 0.000 claims 2
- MJYQFWSXKFLTAY-OVEQLNGDSA-N (2r,3r)-2,3-bis[(4-hydroxy-3-methoxyphenyl)methyl]butane-1,4-diol;(2r,3r,4s,5s,6r)-6-(hydroxymethyl)oxane-2,3,4,5-tetrol Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O.C1=C(O)C(OC)=CC(C[C@@H](CO)[C@H](CO)CC=2C=C(OC)C(O)=CC=2)=C1 MJYQFWSXKFLTAY-OVEQLNGDSA-N 0.000 claims 1
- 241000251468 Actinopterygii Species 0.000 claims 1
- 244000144730 Amygdalus persica Species 0.000 claims 1
- 108010082495 Dietary Plant Proteins Proteins 0.000 claims 1
- 229920002148 Gellan gum Polymers 0.000 claims 1
- 229920002907 Guar gum Polymers 0.000 claims 1
- 229920000084 Gum arabic Polymers 0.000 claims 1
- 229920000569 Gum karaya Polymers 0.000 claims 1
- 229920002752 Konjac Polymers 0.000 claims 1
- 229920000161 Locust bean gum Polymers 0.000 claims 1
- 235000006040 Prunus persica var persica Nutrition 0.000 claims 1
- 241000206572 Rhodophyta Species 0.000 claims 1
- 241000934878 Sterculia Species 0.000 claims 1
- 229920001615 Tragacanth Polymers 0.000 claims 1
- 235000010489 acacia gum Nutrition 0.000 claims 1
- 239000000205 acacia gum Substances 0.000 claims 1
- 235000010443 alginic acid Nutrition 0.000 claims 1
- 229920000615 alginic acid Polymers 0.000 claims 1
- 239000012164 animal wax Substances 0.000 claims 1
- 239000000420 anogeissus latifolia wall. gum Substances 0.000 claims 1
- 239000000305 astragalus gummifer gum Substances 0.000 claims 1
- 239000002775 capsule Substances 0.000 claims 1
- 150000001720 carbohydrates Chemical class 0.000 claims 1
- 235000010418 carrageenan Nutrition 0.000 claims 1
- 239000000679 carrageenan Substances 0.000 claims 1
- 229920001525 carrageenan Polymers 0.000 claims 1
- 229940113118 carrageenan Drugs 0.000 claims 1
- 235000019688 fish Nutrition 0.000 claims 1
- 235000004426 flaxseed Nutrition 0.000 claims 1
- 235000010492 gellan gum Nutrition 0.000 claims 1
- 239000000216 gellan gum Substances 0.000 claims 1
- 235000010417 guar gum Nutrition 0.000 claims 1
- 239000000665 guar gum Substances 0.000 claims 1
- 229960002154 guar gum Drugs 0.000 claims 1
- 235000019314 gum ghatti Nutrition 0.000 claims 1
- 235000010494 karaya gum Nutrition 0.000 claims 1
- 239000000231 karaya gum Substances 0.000 claims 1
- 229940039371 karaya gum Drugs 0.000 claims 1
- 239000000252 konjac Substances 0.000 claims 1
- 235000019823 konjac gum Nutrition 0.000 claims 1
- 235000010420 locust bean gum Nutrition 0.000 claims 1
- 239000000711 locust bean gum Substances 0.000 claims 1
- 230000002906 microbiologic effect Effects 0.000 claims 1
- 150000005846 sugar alcohols Chemical class 0.000 claims 1
- 239000012178 vegetable wax Substances 0.000 claims 1
- 229920001285 xanthan gum Polymers 0.000 claims 1
- 235000010493 xanthan gum Nutrition 0.000 claims 1
- 239000000230 xanthan gum Substances 0.000 claims 1
- 229940082509 xanthan gum Drugs 0.000 claims 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 claims 1
- 238000004321 preservation Methods 0.000 abstract description 6
- 244000005700 microbiome Species 0.000 abstract description 4
- 239000000243 solution Substances 0.000 description 43
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 36
- 238000000889 atomisation Methods 0.000 description 34
- 238000010438 heat treatment Methods 0.000 description 34
- 230000004083 survival effect Effects 0.000 description 33
- 238000003756 stirring Methods 0.000 description 20
- 239000007788 liquid Substances 0.000 description 13
- 210000004051 gastric juice Anatomy 0.000 description 10
- 230000000968 intestinal effect Effects 0.000 description 10
- 241000894006 Bacteria Species 0.000 description 9
- 241000186000 Bifidobacterium Species 0.000 description 9
- 239000000047 product Substances 0.000 description 9
- 210000001035 gastrointestinal tract Anatomy 0.000 description 8
- 210000000941 bile Anatomy 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- 230000009286 beneficial effect Effects 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 6
- 238000002156 mixing Methods 0.000 description 6
- 238000003860 storage Methods 0.000 description 6
- 230000001580 bacterial effect Effects 0.000 description 5
- 235000013305 food Nutrition 0.000 description 5
- 238000005303 weighing Methods 0.000 description 5
- 229920001661 Chitosan Polymers 0.000 description 4
- 244000068988 Glycine max Species 0.000 description 4
- 235000010469 Glycine max Nutrition 0.000 description 4
- 241000186660 Lactobacillus Species 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 229940039696 lactobacillus Drugs 0.000 description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
- 239000003921 oil Substances 0.000 description 4
- 235000019198 oils Nutrition 0.000 description 4
- 239000007921 spray Substances 0.000 description 4
- 108020004465 16S ribosomal RNA Proteins 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 108020004414 DNA Proteins 0.000 description 3
- 241000192001 Pediococcus Species 0.000 description 3
- 241000194017 Streptococcus Species 0.000 description 3
- 238000000246 agarose gel electrophoresis Methods 0.000 description 3
- 238000007664 blowing Methods 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 238000005243 fluidization Methods 0.000 description 3
- 239000001963 growth medium Substances 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 239000004310 lactic acid Substances 0.000 description 3
- 235000014655 lactic acid Nutrition 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 238000012163 sequencing technique Methods 0.000 description 3
- 238000001291 vacuum drying Methods 0.000 description 3
- 239000000080 wetting agent Substances 0.000 description 3
- BHQCQFFYRZLCQQ-UHFFFAOYSA-N (3alpha,5alpha,7alpha,12alpha)-3,7,12-trihydroxy-cholan-24-oic acid Natural products OC1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 BHQCQFFYRZLCQQ-UHFFFAOYSA-N 0.000 description 2
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 2
- 239000004380 Cholic acid Substances 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- 241000194036 Lactococcus Species 0.000 description 2
- 241000192132 Leuconostoc Species 0.000 description 2
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 2
- 244000113306 Monascus purpureus Species 0.000 description 2
- 235000002322 Monascus purpureus Nutrition 0.000 description 2
- 238000012408 PCR amplification Methods 0.000 description 2
- 241000186429 Propionibacterium Species 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 2
- 238000012300 Sequence Analysis Methods 0.000 description 2
- 241000191940 Staphylococcus Species 0.000 description 2
- 241001052560 Thallis Species 0.000 description 2
- 239000011543 agarose gel Substances 0.000 description 2
- 239000001110 calcium chloride Substances 0.000 description 2
- 229910001628 calcium chloride Inorganic materials 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 235000019416 cholic acid Nutrition 0.000 description 2
- BHQCQFFYRZLCQQ-OELDTZBJSA-N cholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 BHQCQFFYRZLCQQ-OELDTZBJSA-N 0.000 description 2
- 229960002471 cholic acid Drugs 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- KXGVEGMKQFWNSR-UHFFFAOYSA-N deoxycholic acid Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 KXGVEGMKQFWNSR-UHFFFAOYSA-N 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 238000000855 fermentation Methods 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- 239000012467 final product Substances 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 235000019359 magnesium stearate Nutrition 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 210000004379 membrane Anatomy 0.000 description 2
- 239000003094 microcapsule Substances 0.000 description 2
- 229940016286 microcrystalline cellulose Drugs 0.000 description 2
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 2
- 239000008108 microcrystalline cellulose Substances 0.000 description 2
- 229940057059 monascus purpureus Drugs 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 238000005507 spraying Methods 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- 101150028074 2 gene Proteins 0.000 description 1
- 241000186361 Actinobacteria <class> Species 0.000 description 1
- 241001134770 Bifidobacterium animalis Species 0.000 description 1
- 241000901050 Bifidobacterium animalis subsp. lactis Species 0.000 description 1
- 241000186146 Brevibacterium Species 0.000 description 1
- LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- 108020000949 Fungal DNA Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 241000235649 Kluyveromyces Species 0.000 description 1
- 244000199866 Lactobacillus casei Species 0.000 description 1
- 235000013958 Lactobacillus casei Nutrition 0.000 description 1
- 241000218588 Lactobacillus rhamnosus Species 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 108010019160 Pancreatin Proteins 0.000 description 1
- 102000057297 Pepsin A Human genes 0.000 description 1
- 108090000284 Pepsin A Proteins 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- VLSOAXRVHARBEQ-UHFFFAOYSA-N [4-fluoro-2-(hydroxymethyl)phenyl]methanol Chemical compound OCC1=CC=C(F)C=C1CO VLSOAXRVHARBEQ-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- GZCGUPFRVQAUEE-SLPGGIOYSA-N aldehydo-D-glucose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O GZCGUPFRVQAUEE-SLPGGIOYSA-N 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 229940040526 anhydrous sodium acetate Drugs 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 229940118852 bifidobacterium animalis Drugs 0.000 description 1
- 229940009289 bifidobacterium lactis Drugs 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000036995 brain health Effects 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 238000001502 gel electrophoresis Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229960001031 glucose Drugs 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 229920003132 hydroxypropyl methylcellulose phthalate Polymers 0.000 description 1
- 229940031704 hydroxypropyl methylcellulose phthalate Drugs 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000006362 insulin response pathway Effects 0.000 description 1
- 210000004347 intestinal mucosa Anatomy 0.000 description 1
- 229940017800 lactobacillus casei Drugs 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000011392 neighbor-joining method Methods 0.000 description 1
- 229940055695 pancreatin Drugs 0.000 description 1
- 229940111202 pepsin Drugs 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 239000008055 phosphate buffer solution Substances 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 238000003752 polymerase chain reaction Methods 0.000 description 1
- -1 polysaccharide compound Chemical class 0.000 description 1
- 229940100467 polyvinyl acetate phthalate Drugs 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 230000000291 postprandial effect Effects 0.000 description 1
- 238000012257 pre-denaturation Methods 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 238000009495 sugar coating Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 230000003313 weakening effect Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/30—Encapsulation of particles, e.g. foodstuff additives
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/04—Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Abstract
The invention provides a bifidobacterium longum variant (Bifidobacterium longum subsp) capable of producing polysaccharide, wherein the bifidobacterium longum strain is preserved in the Guangdong province microorganism strain collection (GDMCC) at the year 2022 and the 11 th month, the preservation address is Guangzhou, and the preservation number is GDMCC No:63000. the bifidobacterium longum variant in the invention is easy to culture, and the yield of the polysaccharide produced and expressed by the bifidobacterium longum variant is higher.
Description
Technical Field
The invention relates to the technical field of microorganisms, in particular to a bifidobacterium longum variant capable of producing polysaccharide and application thereof.
Background
Bifidobacterium longum (Bifidobacterium longum subsp) is a gram-positive, spore-free, motile-free, catalase-negative anaerobic bacterium. In taxonomies bifidobacteria belong to the class actinomycetes, the heterolactic fermentation, the fermentation end products being mainly acetic acid and lactic acid. Bifidobacteria are bacteria that are frequently present in the human intestinal tract and represent about 4.4-6.9% of the total bacterial count in the human intestinal tract. Bifidobacteria are beneficial to human body, such as inhibiting the growth of pathogenic microorganisms, regulating intestinal flora balance, resisting tumor and anticancer activity, treating diarrhea, enhancing body immunity, reducing cholesterol, etc.
Polysaccharides are non-starch polysaccharides formed by connecting D-glucose with a glucosidic bond, and are widely found in nature. The polysaccharide plays an important role in promoting health and preventing diseases, has positive effects in controlling postprandial blood sugar and weakening insulin response, reducing cholesterol and hyperlipidemia, enhancing organism immunity, protecting intestinal brain health and the like, and has great potential for developing functional foods, medical care, food additives and other health industry fields.
Probiotics must pass through the gastric environment to reach the intestinal tract in large amounts of viable bacteria and colonize the intestinal mucosa to exert their physiological functions. In order to ensure the survival rate of the probiotics and maintain the physiological activity of the probiotics and improve the storage stability of the probiotics in the shelf life of products, more research is currently being carried out at home and abroad on microcapsule embedding technology of the probiotics. In the embedding technology, the survival rate and stability of probiotics mainly depend on the concentration and types of thalli, the types of microcapsule wall materials, the outlet temperature of a spray dryer and the like, the influence factors are more, the preparation process is complex, three to four layers or more often need to be embedded, and the death of thalli in the embedding process cannot be effectively avoided, so that the number of viable probiotics of a final product is very low and the production cost is high.
Therefore, there is an urgent need to find a pellet probiotic preparation which has a simple coating process, good storage stability and high survival rate of probiotics, can reach the intestinal tract through the survival of strong acid gastric juice, and improves the health of the intestinal tract.
Disclosure of Invention
One of the technical problems to be solved by the invention is to provide a bifidobacterium longum (Bifidobacterium longum subsp) capable of producing polysaccharide, wherein the bifidobacterium longum strain is preserved in the Guangdong province microorganism strain preservation center (GDMCC) at the year of 2022 and the preservation number is GDMCC No:63000.
alternatively, the bifidobacterium longum DNA sequence is SEQ ID No.1.
Alternatively, the bifidobacterium longum is isolated from sea water in the beach of the south China sea.
Alternatively, the bifidobacterium longum expresses a polysaccharide yield of 0.4-0.6%.
The second technical problem to be solved by the invention is to provide an application of polysaccharide expressed by bifidobacterium longum in a crystal ball probiotic preparation.
In order to solve the problems, the invention aims to provide a three-layer coated pellet probiotic preparation, which comprises a first grease coating layer for pellets of pellet probiotics, a second isolation coating layer for coating the pellets of probiotics and a third enteric coating layer for coating the isolation layer from inside to outside; the preparation method comprises extruding, rounding and embedding probiotics with slow release adjuvants, spraying oil to form a first coating layer to obtain pellet, using polysaccharide solution produced and expressed by Bifidobacterium longum variant as coating solution, performing second layer isolation coating, sieving, using intestinal solution to perform third layer coating, and sieving to obtain the final product.
The invention is realized by the following technical scheme:
the three-layer coated pellet probiotic preparation comprises a first grease coating layer of pellet probiotic pellets, a second isolation coating layer for wrapping the probiotic pellets and a third enteric coating layer for wrapping the isolation layer from inside to outside; the crystal ball probiotic micro-pellets are prepared by extruding and rounding probiotic concentrated solution and/or probiotic powder and food-grade auxiliary materials thereof, and then spraying grease; the second layer of isolation coating is made of polysaccharide material; the third enteric coating is an enteric material.
The probiotics comprise beneficial bacteria and/or beneficial fungi, wherein the beneficial bacteria are selected from any one or a combination of at least two of bifidobacterium, lactobacillus mucilaginosus, lactobacillus, streptococcus, lactococcus, propionibacterium, leuconostoc, pediococcus, weizmann bacteria, zoococcus and staphylococcus; the beneficial fungus is selected from any one or a combination of at least two of Bifidobacterium, lactobacillus casei, lactobacillus mucilaginosus, lactobacillus guangdaliensis, streptococcus, lactococcus, propionibacterium, leuconostoc, pediococcus, weizmann, pediococcus, staphylococcus, kluyveromyces, saccharomyces cerevisiae, brevibacterium, monascus purpureus, or Monascus purpureus.
The preparation method of the crystal ball probiotic preparation comprises the following steps:
(1) Dissolving the polysaccharide material in water to prepare a solution with the mass concentration of 1-15%, taking the solution as a second coating solution, coating the solution by using a fluidized bed, and sieving the solution to obtain a second coating;
(2) The enteric-coated material is prepared into a solution with the mass percentage concentration of 5-20% by using ethanol solution or absolute ethanol with the volume concentration of 60-85% as a third coating solution, and the third coating is obtained by coating by using a fluidized bed and sieving.
Compared with the prior art, the invention has the following advantages and beneficial effects:
1. the invention separates and identifies a strain of polysaccharide-producing bifidobacterium longum (Bifidobacterium longum subsp), more particularly a strain of polysaccharide-producing bifidobacterium hainanensis variant. The strain is determined to be bifidobacterium longum by genome sequence analysis and construction of phylogenetic tree.
2. Compared with the prior art, the bifidobacterium longum is easy to culture, and the yield and activity of the polysaccharide produced and expressed by the bifidobacterium longum are higher.
3. The crystal ball probiotics have good storage stability, can keep activity in the normal temperature storage process, and effectively solve the problem that the number of viable probiotics is greatly reduced in the common processing and selling links of the probiotic products;
4. the survival rate of probiotics is high, and the probiotics are not easy to inactivate in gastric juice and bile;
5. the probiotics can be slowly released in the intestinal tract and can be smoothly planted in the intestinal tract;
6. the operation is simple and the process is easy to control.
Drawings
FIG. 1 is a colony chart of strain XNY6069 in example 1 of the present invention;
FIG. 2 is a microscopic image of strain XNY6069 in example 1 of the present invention;
FIG. 3 is an agarose gel electrophoresis chart of PCR amplified products of strain XNY6069 in example 2 of the present invention;
FIG. 4 is a phylogenetic tree of strain XNY6069 in example 2 of the present invention.
Detailed Description
The present invention will be described in further detail with reference to the following examples, for the purpose of making the objects, technical solutions and advantages of the present invention more apparent, and the description thereof is merely illustrative of the present invention and not intended to be limiting.
EXAMPLE 1 acquisition of Bifidobacterium longum (Bifidobacterium longum subsp) Strain
1. Preparation of culture Medium
Culture medium (g/L): 10.0 parts of beef extract, 5.0 parts of peptone, 3.0 parts of yeast powder, 5.0 parts of D (+) -glucose, 1.0 parts of soluble starch, 5.0 parts of sodium chloride, 3.0 parts of anhydrous sodium acetate and 0.5 parts of L-cysteine hydrochloride
2. Screening of strains
Collecting some seawater samples from the coastal beach of Hainan, culturing the collected samples one by one, coating the samples in MRS flat plate culture medium after gradient dilution, numbering corresponding flat plates respectively, placing the flat plates in a constant temperature incubator at 37 ℃ for anaerobic culture for 24 hours, selecting single bacterial colonies with better growth vigor, and respectively inoculating the single bacterial colonies to test tubes for secondary culture for bacterial preservation. The colony profile was apparent and the color was off-white (see FIGS. 1 and 2).
EXAMPLE 2 Gene sequence analysis of Bifidobacterium longum (Bifidobacterium longum subsp) Strain
1. Fungal DNA genome extraction:
the strain broth obtained in example 1 was centrifuged, and the precipitate was extracted by CTAB method to obtain 16 srDNA.
2. PCR amplification of 16S rDNA was performed on this strain:
and (3) PCR amplification: primers 515F and 806R were PCR amplified, 515F was 5'-GTGYCAGCMGCCGCGGTAA-3', and 806R was 5'-GGACTACNVGGGTWTCTAAT-3'. The PCR reaction system is as follows: 25. Mu.L of TAQ enzyme, 2. Mu.L of 515F primer, 2. Mu.L of 806R primer, 5. Mu.L of DNA template and 16. Mu.L of sterile water. The PCR amplification procedure was: pre-denaturation at 94℃for 5min; denaturation at 94℃for 60s, annealing at 48℃for 60s, extension at 72℃for 60s,28 cycles; the reaction was terminated by extension at 72℃for 7min and at 4 ℃. Gel electrophoresis and PCR product gel recovery: the PCR products were identified by 1.5% agarose gel electrophoresis. The target PCR product was recovered and purified using a rapid agarose gel DNA recovery kit (Beijing Baitaike Biotechnology Co., ltd.) and subjected to 16S rDNA sequencing. The PCR products were identified by 1% agarose gel electrophoresis (see FIG. 3). It was observed whether or not the target band was amplified.
3.16S rDNA sequencing and analysis
The target PCR product is recovered and purified by using a rapid agarose gel DNA recovery kit (Beijing Baitaike Biotechnology Co., ltd.), and the purified PCR product is sent to Shanghai Biotechnology engineering service Co., ltd for sequencing, and the gene sequence is shown as SEQ ID NO: 1. The measured sequence was submitted to GENBANK from NCBI, U.S. to obtain a similar sequence, which was analyzed by BLAST tools and DNAMAN software for alignment and phylogenetic tree construction using the Neighbor-Joining method, as shown in FIG. 4.
The similarity of the strain to Bifidobacterium longum subsp is found to be 98.38% higher by phylogenetic tree, so that the strain can be determined as a marine bifidobacterium longum, which we named Bifidobacterium longum subsp XNY6069.
The bifidobacterium longum strain obtained by the screening is named as bifidobacterium longum strain (Bifidobacterium longum subsp), the strain number is XNY6069, the 2022 is 11 and 28 days, and the bifidobacterium longum strain is preserved in Guangdong province microorganism strain preservation center (GDMCC), the preservation address is Guangzhou, and the preservation number is GDMCC No:63000.
EXAMPLE 3 yield of polysaccharide expressed by Bifidobacterium longum (Bifidobacterium longum subsp) Strain
Polysaccharide yield determination method: centrifuging bacterial liquid, and weighing supernatant fluid M; then adding absolute ethyl alcohol with the mass 2 times of that of the supernatant, stirring and dehydrating by a glass rod for 10min, precipitating by alcohol, filtering floccules, putting the floccules on dried filter paper, and then adding a prepared ethanol solution for washing and filtering; and (5) after the filtration is finished, placing the mixture into an oven, baking the mixture to constant weight, and weighing the mass m. The calculated polysaccharide yield was M/m=0.4%.
Example 4 this example provides a pellet extrusion spheronization first layer oil coating preparation method as follows:
(1) Uniformly mixing 36g of microcrystalline cellulose, 52.8g of sodium alginate, 36g of lactose and 48g of streptococcus acidophilus with 3000 hundred million cfu/g;
(2) 120g of pure water was mixed with 7.2g of calcium chloride to form a 6% aqueous solution of calcium chloride, which was used as a wetting agent;
(3) Slowly adding the component (2) into the component (1), and uniformly mixing;
(4) The above mixture was extruded at a speed of 10rmp and then rounded in a spheronizer for 5 minutes at 1500 rmp;
(5) Drying by using a low-temperature vacuum drying oven until the moisture content of the material is less than or equal to 5%;
(6) The first layer of grease coating is carried out by a fluidized bed, the used grease is any one or the combination of at least two of solid palm oil and fish oil, the softening point of the grease is 45-60 ℃, a spray gun is provided with a heating and heat-preserving device to ensure the normal atomization of the grease, the atomization pressure is 2bar, the blowing frequency is 30Hz, the heating temperature is 60 ℃, the material temperature is 36 ℃, the particles in the bed continuously flow to form a good fluidization state, the weight of the coating is increased by 1-2%, and the fluidized coating is sieved by a sieve of 20-40 meshes.
Example 5 this example provides a pellet extrusion spheronization first layer oil coating preparation method as follows:
(1) Weighing 100g2000 hundred million cfu/g lactobacillus rhamnosus, 80g1000 hundred million cfu/g bifidobacterium lactis, 30g palm oil, 9.6g magnesium stearate and 7.2g microcrystalline cellulose, and uniformly mixing;
(2) Weighing 60g of pure water as a wetting agent;
(3) Slowly adding the component (2) into the component (1), and uniformly mixing;
(4) The above mixture was extruded at a speed of 10rmp and then rounded in a spheronizer for 5 minutes at 1500 rmp;
(5) Drying by using a low-temperature vacuum drying oven until the moisture content of the material is less than or equal to 5%;
(6) The first layer of grease coating is carried out by a fluidized bed, the used grease is any one or the combination of at least two of solid palm oil and fish oil, the softening point of the grease is 45-60 ℃, a spray gun is provided with a heating and heat-preserving device to ensure the normal atomization of the grease, the atomization pressure is 2bar, the blowing frequency is 30Hz, the heating temperature is 60 ℃, the material temperature is 36 ℃, the particles in the bed continuously flow to form a good fluidization state, the weight of the coating is increased by 1-2%, and the fluidized coating is sieved by a sieve of 20-40 meshes.
Example 6 this example provides a pellet extrusion spheronization first layer oil coating preparation method as follows:
(1) Weighing 222g6000 hundred million cfu/g of bifidobacterium animalis, 31g of solid fish oil, 15g of magnesium stearate and 31g of erythritol, and uniformly mixing;
(2) 180g of pure water was weighed as a wetting agent;
(3) Slowly adding the component (2) into the component (1), and uniformly mixing;
(4) The above mixture was extruded at a speed of 10rmp and then rounded in a spheronizer for 5 minutes at 1500 rmp;
(5) Drying by using a low-temperature vacuum drying oven until the moisture content of the material is less than or equal to 5%;
(6) The first layer of grease coating is carried out by a fluidized bed, the used grease is any one or the combination of at least two of solid palm oil and fish oil, the softening point of the grease is 45-60 ℃, a spray gun is provided with a heating and heat-preserving device to ensure the normal atomization of the grease, the atomization pressure is 2bar, the blowing frequency is 30Hz, the heating temperature is 60 ℃, the material temperature is 36 ℃, the particles in the bed continuously flow to form a good fluidization state, the weight of the coating is increased by 1-2%, and the fluidized coating is sieved by a sieve of 20-40 meshes.
The viable count in the pellet probiotic pellets of examples 4 to 6 was measured and the survival rate calculated according to GB 4789.35-2016 food safety national Standard food microbiology test lactic acid bacteria test, respectively, and the specific test results are shown in Table 1:
table 1 table of viable count of pellet probiotics of examples 4 to 6
As can be seen from Table 1, the survival rate of the viable count of the pellet in example 6 is highest and reaches more than 90%, so that the pellet in example 6 is selected for the subsequent coating process.
Example 7
1. And (2) coating a second layer: 10g of pullulan is added into 190g of hot water with the temperature of 90 ℃ and uniformly stirred at constant temperature to prepare a second layer of coating solution. Coating by using a fluidized bed, wherein the atomization pressure is 2.5bar, the heating temperature is 56 ℃, the material temperature is 36 ℃, and the second layer of coated crystal balls are obtained by sieving with a 20-40 mesh sieve.
2. And (3) coating a third layer: firstly, adding 80g of absolute ethyl alcohol into 20g of lac, stirring and dissolving the lac into transparent liquid at normal temperature, and adding 2g of glycerol to prepare a third layer coating solution. Coating by a fluidized bed, wherein the atomization pressure is 2.5bar, the heating temperature is 50 ℃, the material temperature is 34 ℃, and the mixture is sieved by a sieve with 20 meshes to 40 meshes to obtain the crystal ball probiotic preparation.
Example 8
1. And (2) coating a second layer: 10g of soybean polysaccharide is added into 190g of hot water with the temperature of 90 ℃ and uniformly stirred at constant temperature to prepare a second coating solution. Coating by using a fluidized bed, wherein the atomization pressure is 2.5bar, the heating temperature is 56 ℃, the material temperature is 36 ℃, and the second layer of coated crystal balls are obtained by sieving with a 20-40 mesh sieve.
2. And (3) coating a third layer: firstly, adding 80g of absolute ethyl alcohol into 20g of lac, stirring and dissolving the lac into transparent liquid at normal temperature, and adding 2g of glycerol to prepare a third layer coating solution. Coating by a fluidized bed, wherein the atomization pressure is 2.5bar, the heating temperature is 50 ℃, the material temperature is 34 ℃, and the mixture is sieved by a sieve with 20 meshes to 40 meshes to obtain the crystal ball probiotic preparation.
Example 9
1. And (2) coating a second layer: 10g of pectin is added into 190g of hot water at 90 ℃ and stirred uniformly at constant temperature to prepare a second coating solution. Coating by using a fluidized bed, wherein the atomization pressure is 2.5bar, the heating temperature is 56 ℃, the material temperature is 36 ℃, and the second layer of coated crystal balls are obtained by sieving with a 20-40 mesh sieve.
2. And (3) coating a third layer: firstly, adding 80g of absolute ethyl alcohol into 20g of lac, stirring and dissolving the lac into transparent liquid at normal temperature, and adding 2g of glycerol to prepare a third layer coating solution. Coating by a fluidized bed, wherein the atomization pressure is 2.5bar, the heating temperature is 50 ℃, the material temperature is 34 ℃, and the mixture is sieved by a sieve with 20 meshes to 40 meshes to obtain the crystal ball probiotic preparation.
Example 10
1. And (2) coating a second layer: firstly, adding 6g of citric acid into 190g of hot water at 90 ℃, then adding 4g of chitosan into the mixture, and uniformly stirring the mixture at constant temperature to prepare a second coating solution. Coating by using a fluidized bed, wherein the atomization pressure is 2.5bar, the heating temperature is 56 ℃, the material temperature is 36 ℃, and the second layer of coated crystal balls are obtained by sieving with a 20-40 mesh sieve.
2. And (3) coating a third layer: firstly, adding 80g of absolute ethyl alcohol into 20g of lac, stirring and dissolving the lac into transparent liquid at normal temperature, and adding 2g of glycerol to prepare a third layer coating solution. Coating by a fluidized bed, wherein the atomization pressure is 2.5bar, the heating temperature is 50 ℃, the material temperature is 34 ℃, and the mixture is sieved by a sieve with 20 meshes to 40 meshes to obtain the crystal ball probiotic preparation.
Example 11
1. And (2) coating a second layer: adding 5g of polysaccharide expressed by bifidobacterium longum into 195g of hot water at 90 ℃ and stirring uniformly at constant temperature to prepare a second coating solution. Coating by using a fluidized bed, wherein the atomization pressure is 2.5bar, the heating temperature is 56 ℃, the material temperature is 36 ℃, and the second layer of coated crystal balls are obtained by sieving with a 20-40 mesh sieve.
2. And (3) coating a third layer: firstly, adding 80g of absolute ethyl alcohol into 20g of lac, stirring and dissolving the lac into transparent liquid at normal temperature, and adding 2g of glycerol to prepare a third layer coating solution. Coating by a fluidized bed, wherein the atomization pressure is 2.5bar, the heating temperature is 50 ℃, the material temperature is 34 ℃, and the mixture is sieved by a sieve with 20 meshes to 40 meshes to obtain the crystal ball probiotic preparation.
Example 12
1. And (2) coating a second layer: and adding 5g of polysaccharide expressed by bifidobacterium longum and 2.5g of pullulan into 142.5g of hot water at 90 ℃ and stirring uniformly at constant temperature to prepare a second coating solution. Coating by using a fluidized bed, wherein the atomization pressure is 2.5bar, the heating temperature is 56 ℃, the material temperature is 36 ℃, and the second layer of coated crystal balls are obtained by sieving with a 20-40 mesh sieve.
2. And (3) coating a third layer: firstly, adding 80g of absolute ethyl alcohol into 20g of lac, stirring and dissolving the lac into transparent liquid at normal temperature, and adding 2g of glycerol to prepare a third layer coating solution. Coating by a fluidized bed, wherein the atomization pressure is 2.5bar, the heating temperature is 50 ℃, the material temperature is 34 ℃, and the mixture is sieved by a sieve with 20 meshes to 40 meshes to obtain the crystal ball probiotic preparation.
Example 13
1. And (2) coating a second layer: 5g of polysaccharide expressed by bifidobacterium longum and 2.5g of soybean polysaccharide are added into 142.5g of hot water at 90 ℃ and stirred uniformly at constant temperature to prepare a second coating solution. Coating by using a fluidized bed, wherein the atomization pressure is 2.5bar, the heating temperature is 56 ℃, the material temperature is 36 ℃, and the second layer of coated crystal balls are obtained by sieving with a 20-40 mesh sieve.
2. And (3) coating a third layer: firstly, adding 80g of absolute ethyl alcohol into 20g of lac, stirring and dissolving the lac into transparent liquid at normal temperature, and adding 2g of glycerol to prepare a third layer coating solution. Coating by a fluidized bed, wherein the atomization pressure is 2.5bar, the heating temperature is 50 ℃, the material temperature is 34 ℃, and the mixture is sieved by a sieve with 20 meshes to 40 meshes to obtain the crystal ball probiotic preparation.
Example 14
1. And (2) coating a second layer: 5g of polysaccharide expressed by bifidobacterium longum and 2.5g of pectin are added into 142.5g of hot water at 90 ℃ and stirred uniformly at constant temperature to prepare a second coating solution. Coating by using a fluidized bed, wherein the atomization pressure is 2.5bar, the heating temperature is 56 ℃, the material temperature is 36 ℃, and the second layer of coated crystal balls are obtained by sieving with a 20-40 mesh sieve.
2. And (3) coating a third layer: firstly, adding 80g of absolute ethyl alcohol into 20g of lac, stirring and dissolving the lac into transparent liquid at normal temperature, and adding 2g of glycerol to prepare a third layer coating solution. Coating by a fluidized bed, wherein the atomization pressure is 2.5bar, the heating temperature is 50 ℃, the material temperature is 34 ℃, and the mixture is sieved by a sieve with 20 meshes to 40 meshes to obtain the crystal ball probiotic preparation.
Example 15
1. And (2) coating a second layer: firstly, adding 6g of citric acid into 142.5g of hot water at 90 ℃, adding 5g of polysaccharide expressed by bifidobacterium longum, then adding 2.5g of chitosan, and uniformly stirring at constant temperature to prepare a second layer of coating solution. Coating by using a fluidized bed, wherein the atomization pressure is 2.5bar, the heating temperature is 56 ℃, the material temperature is 36 ℃, and the second layer of coated crystal balls are obtained by sieving with a 20-40 mesh sieve.
2. And (3) coating a third layer: firstly, adding 80g of absolute ethyl alcohol into 20g of lac, stirring and dissolving the lac into transparent liquid at normal temperature, and adding 2g of glycerol to prepare a third layer coating solution. Coating by a fluidized bed, wherein the atomization pressure is 2.5bar, the heating temperature is 50 ℃, the material temperature is 34 ℃, and the mixture is sieved by a sieve with 20 meshes to 40 meshes to obtain the crystal ball probiotic preparation.
Example 16
1. And (2) coating a second layer: and adding 5g of polysaccharide expressed by bifidobacterium longum and 2.5g of pullulan into 142.5g of hot water at 90 ℃ and stirring uniformly at constant temperature to prepare a second coating solution. Coating by using a fluidized bed, wherein the atomization pressure is 2.5bar, the heating temperature is 56 ℃, the material temperature is 36 ℃, and the second layer of coated crystal balls are obtained by sieving with a 20-40 mesh sieve.
2. And (3) coating a third layer: firstly, 10g of zein is added with 90g of 80% ethanol, stirred and dissolved at 60 ℃ to form transparent liquid, and 1g of glycerol is added to prepare a third coating solution. Coating by a fluidized bed, wherein the atomization pressure is 2.5bar, the heating temperature is 50 ℃, the material temperature is 34 ℃, and the mixture is sieved by a sieve with 20 meshes to 40 meshes to obtain the crystal ball probiotic preparation.
Example 17
1. And (2) coating a second layer: and adding 5g of polysaccharide expressed by bifidobacterium longum and 2.5g of pullulan into 142.5g of hot water at 90 ℃ and stirring uniformly at constant temperature to prepare a second coating solution. Coating by using a fluidized bed, wherein the atomization pressure is 2.5bar, the heating temperature is 56 ℃, the material temperature is 36 ℃, and the second layer of coated crystal balls are obtained by sieving with a 20-40 mesh sieve.
2. And (3) coating a third layer: 10g of polyvinyl acetate phthalate is firstly added with 90g of absolute ethyl alcohol, stirred and dissolved at 60 ℃ to form transparent liquid, and 1g of glycerol is added to prepare a third coating solution. Coating by a fluidized bed, wherein the atomization pressure is 2.5bar, the heating temperature is 50 ℃, the material temperature is 34 ℃, and the mixture is sieved by a sieve with 20 meshes to 40 meshes to obtain the crystal ball probiotic preparation.
Example 18
1. And (2) coating a second layer: and adding 5g of polysaccharide expressed by bifidobacterium longum and 2.5g of pullulan into 142.5g of hot water at 90 ℃ and stirring uniformly at constant temperature to prepare a second coating solution. Coating by using a fluidized bed, wherein the atomization pressure is 2.5bar, the heating temperature is 56 ℃, the material temperature is 36 ℃, and the second layer of coated crystal balls are obtained by sieving with a 20-40 mesh sieve.
2. And (3) coating a third layer: 10g of hydroxypropyl methylcellulose phthalate is firstly taken, 90g of absolute ethyl alcohol is added, stirring and dissolving are carried out at 60 ℃ to obtain transparent liquid, and 1g of glycerol is added to prepare the third coating solution. Coating by a fluidized bed, wherein the atomization pressure is 2.5bar, the heating temperature is 50 ℃, the material temperature is 34 ℃, and the mixture is sieved by a sieve with 20 meshes to 40 meshes to obtain the crystal ball probiotic preparation.
Example 19
1. And (2) coating a second layer: and adding 5g of polysaccharide expressed by bifidobacterium longum and 2.5g of pullulan into 142.5g of hot water at 90 ℃ and stirring uniformly at constant temperature to prepare a second coating solution. Coating by using a fluidized bed, wherein the atomization pressure is 2.5bar, the heating temperature is 56 ℃, the material temperature is 36 ℃, and the second layer of coated crystal balls are obtained by sieving with a 20-40 mesh sieve.
2. And (3) coating a third layer: the third coating solution was prepared by commercially available opadry. Coating by a fluidized bed, wherein the atomization pressure is 2.5bar, the heating temperature is 50 ℃, the material temperature is 34 ℃, and the mixture is sieved by a sieve with 20 meshes to 40 meshes to obtain the crystal ball probiotic preparation.
Example 20
1. And (2) coating a second layer: and adding 5g of polysaccharide expressed by bifidobacterium longum and 2.5g of pullulan into 142.5g of hot water at 90 ℃ and stirring uniformly at constant temperature to prepare a second coating solution. Coating by using a fluidized bed, wherein the atomization pressure is 2.5bar, the heating temperature is 56 ℃, the material temperature is 36 ℃, and the second layer of coated crystal balls are obtained by sieving with a 20-40 mesh sieve.
2. And (3) coating a third layer: commercially availableA third coating solution is prepared. Coating by a fluidized bed, wherein the atomization pressure is 2.5bar, the heating temperature is 50 ℃, the material temperature is 34 ℃, and the mixture is sieved by a sieve with 20 meshes to 40 meshes to obtain the crystal ball probiotic preparation.
Example 21 Effect of coating films made from different coating materials on preparation of pellet probiotic formulations
The prepared probiotic preparation is respectively detected in low temperature, normal temperature storage stability, survival rate in gastric juice, survival rate in bile and survival rate in intestinal juice.
The number of viable probiotic bacteria in the probiotic preparation was detected according to GB 4789.35-2016 food safety national Standard food microbiology test lactic acid bacteria test, and the survival rate was calculated.
The method for detecting the storage stability at low temperature and normal temperature comprises the following steps: respectively storing at-4deg.C and 25deg.C for 3 months, and detecting survival rate of probiotics; the method for detecting the survival rate in gastric juice comprises the following steps: preparing artificial gastric juice (containing 3.2mg/ml pepsin and 0.2% (w/v) NaCl solution) according to a pharmacopoeia method, wherein the pH is 1.2, putting the probiotic preparation into an artificial gastric juice environment at 37 ℃, and detecting the survival rate of probiotics after 2 hours; the detection method of the survival rate in bile comprises the following steps: preparing artificial simulated cholic acid (2% (w/v) pig bile extract) according to a pharmacopoeia method, putting a probiotic preparation into a simulated cholic acid environment at 37 ℃, and detecting the survival rate of probiotics after 2 hours; the method for detecting the survival rate in intestinal juice comprises the following steps: preparing artificial simulated intestinal juice (containing 1% (w/v) pancreatin) according to a pharmacopoeia method, putting the probiotic preparation into a simulated intestinal juice environment at 37 ℃, and detecting the survival rate of the probiotics after 40 minutes; the calculation formula of the survival rate: survival (%) = (N/N0) ×100, N is the number of plated colonies after treatment, N0 is the number of plated colonies before treatment, and the number of colonies is obtained: about 1g of the collected probiotic preparation is added into 1000mL of phosphate buffer solution (pH=6.8-7.0), dispersed for 5min by a homogenizer, a proper amount of slurry is taken, diluted by a certain multiple and coated on MRS agar medium, and all colony numbers on the plate are counted after culturing for 72+/-2 h at 36 ℃. The test results are shown in Table 2.
TABLE 2 influence of coating films prepared from different single polysaccharide coatings on preparation of pellet probiotic formulations
As can be seen from table 2, due to the different polysaccharide types, when the third enteric coating material is the same and the second layer is coated with a single polysaccharide, only the probiotic preparation prepared by using the polysaccharide coating expressed by bifidobacterium longum can obtain better low temperature, normal temperature stability, better gastric juice survival rate and higher survival rate in intestinal tract. Therefore, the polysaccharide expressed by bifidobacterium longum is most suitable as a probiotic sugar coating material.
TABLE 3 influence of coating films prepared from different polysaccharides on preparation of pellet probiotic formulations
Sample of | Survival rate at-4℃% | Survival rate at 25℃% | Survival rate in gastric juice% | Survival rate in bile% | Survival rate in intestinal juice% |
Example 12 | 99.16 | 98.82 | 96.17 | 95.21 | 88.87 |
Example 13 | 94.51 | 89.68 | 87.52 | 84.23 | 77.61 |
Example 14 | 93.86 | 88.91 | 86.71 | 85.42 | 78.12 |
Example 15 | 95.27 | 90.35 | 88.19 | 85.64 | 79.18 |
As can be seen from Table 3, when the polysaccharide expressed by Bifidobacterium longum and other commercially available conventional polysaccharide compound coatings are adopted, the probiotic pellet coated with the polysaccharide-pullulan compound coating expressed by Bifidobacterium longum has better coating effect, better low-temperature and normal-temperature stability, and very high survival rate in gastric juice, bile and intestinal juice.
As can be seen from comparison of examples 7, 11 and 3 and example 12 in Table 2, the polysaccharide expressed by bifidobacterium longum alone or the pullulan polysaccharide alone is used for coating the polysaccharide which is not expressed by bifidobacterium longum-pullulan compound coating effect is good, which indicates that the polysaccharide expressed by bifidobacterium longum and the pullulan can play a synergistic effect, and the performance of the crystal ball probiotics is further improved. The membrane structure is more compact and can better resist the external severe environment due to the fact that the pullulan polysaccharide and the polysaccharide expressed by bifidobacterium longum are crosslinked into a membrane through a hydrogen bond interpenetrating network.
In addition, the effect of the polysaccharide expressed by the bifidobacterium longum and the compound coating of the soybean polysaccharide, the pectin and the chitosan are respectively compared, and researches prove that the polysaccharide expressed by the bifidobacterium longum has no obvious synergistic effect when being compounded with the soybean polysaccharide, the pectin and the chitosan.
TABLE 4 influence of coating films made of different enteric materials on preparation of pellet probiotic formulations
Sample of | Survival rate at-4℃% | Survival rate at 25℃% | Survival rate in gastric juice% | Survival rate in bile% | Survival rate in intestinal juice% |
Example 16 | 99.21 | 98.53 | 96.28 | 95.37 | 88.58 |
Example 17 | 99.42 | 98.61 | 96.42 | 95.81 | 88.24 |
Example 18 | 99.35 | 98.49 | 96.37 | 95.73 | 88.39 |
Example 19 | 99.43 | 98.27 | 96.48 | 95.68 | 88.41 |
Example 20 | 99.37 | 98.39 | 96.51 | 95.54 | 88.62 |
As can be seen from Table 4, when the second layer adopts the polysaccharide expressed by Bifidobacterium longum-pullulan compound coating and the third layer adopts different enteric coating materials, the coating effect is not very different, indicating that the coating is prepared from different enteric materials
The coating film has no influence on the preparation of the crystal ball probiotic preparation, namely, when the second layer adopts polysaccharide expressed by bifidobacterium longum-pullulan to be coated in a compounding way and then the third layer is coated in an enteric coating way, the enteric coating material matched with the second layer is not needed to be selected, so that the universality is strong, the simplicity and convenience are realized, and the applicability is wide.
Although the present invention is disclosed above, the present invention is not limited thereto. For example, the application range of the composition in medicine and food can be expanded. Various changes and modifications may be made by one skilled in the art without departing from the spirit and scope of the invention, and the scope of the invention should be assessed accordingly to that of the appended claims.
Sequence(s)
SEQ ID NO:1
TAGGGAAATGTGGGGGCGTGCCTTACCATTGCAAGTCGAACGGGATCCATCGGGCTTTGCTTGGTGGTGAGAGTGGCGAACGGGTGAGTAATGCGTGACCGACCTGCCCCATACACCGGAATAGCTCCTGGAAACGGGTGGTAATGCCGGATGTTCCAGTTGATCGCATGGTCTTCTGGGAAAGCTTTCGCGGTATGGGATGGGGTCGCGTCCTATCAGCTTGACGGCGGGGTAACGGCCCACCGTGGCTTCGACGGGTAGCCGGCCTGAGAGGGCGACCGGCCACATTGGGACTGAGATACGGCCCCTACTCCTACGGGAGGCAGCAGTGGGGAATATTGCACAATGGGCGCAAGCCTGATGCAGCGACGCCGCGTGAGGGATGGAGGCCTTCGGGTTGTAAACCTCTTTTATCGGGGAGCAAGCGTGAGTGAGTTTACCCGTTGAATAAGCACCGGCTAACTACGTGCCAGCAGCCGCGGTAATACGTAGGGCGCAAGCGTTATCCGGAATTATTGGGCGTAAAGGGCTCGTAGGCGGTTCGTCGCGTCCGGTGTGAAAGTCCATCGCTTAACGGTGGATCCGCGCCGGGTACGGGCGGGCTTGAGTGCGGTAGGGGAGACTGGAATTCCCGGTGTAACGGTGGAATGTGTATATATCGGGAAGAACACCAATGGCGAAGGCATGTCTCTGGACCGTTACTGACGCTGAGGAGCGAAAAGCGTGGGGAGCGAAAAAGGATTAGATACCCTGGTAGTCCACGCCCGCAGACGGT。
Claims (5)
1. A bifidobacterium longum XNY6069 strain capable of producing polysaccharide, which is characterized in that: the bifidobacterium longum strain was deposited at the collection of microbiological strains (GDMCC) in the cantonese province at 12 months 22 of 2022 under the deposit number GDMCC No:63000; the bifidobacterium longum is separated from sea water in the beach of the south China sea.
2. A method for preparing a three-layer coated crystal ball probiotic preparation, which is characterized by comprising the following steps: the capsule comprises a first grease coating layer of the pellet, a second isolation coating layer for wrapping the pellet, and a third enteric coating layer for wrapping the isolation layer from inside to outside; the crystal ball probiotic micro-pellets are prepared from probiotic concentrated solution and/or probiotic powder and food-grade auxiliary materials through extrusion and spheronization;
the first grease coating layer comprises any one or the combination of two of solid palm oil and solid fish oil; the second barrier coating comprises a polysaccharide expressed by a strain of bifidobacterium longum according to claim 1 or a combination of a polysaccharide expressed by a strain of bifidobacterium longum according to claim 1 and pullulan; the third enteric coating is made of enteric materials and comprises one or more of shellac, alcohol-soluble zein, fibroin, acrylic resin and derivatives thereof, cellulose and derivatives thereof, and polyvinyl alcohol derivatives.
3. A method of preparing a three-layer coated pellet probiotic formulation according to claim 2, wherein: the food-grade auxiliary materials comprise any one or a combination of at least two of celluloses, saccharides, sugar alcohols, starches, natural colloids, animal and vegetable proteins, grease, animal and vegetable waxes and alginates; the natural colloid comprises guar gum, locust bean gum, flaxseed gum, acacia gum, tragacanth gum, ghatti gum, karaya gum, peach gum, pectin, konjac gum, gelatin, fish gelatin, xanthan gum, gellan gum, agar, carrageenan, and/or red algae gum.
4. The method for preparing the pellet probiotic preparation according to claim 2, comprising the following steps:
(1) Dissolving the polysaccharide material in water to prepare a solution with the mass concentration of 1-15%, taking the solution as a second coating solution, coating the solution by using a fluidized bed, and sieving the solution to obtain a second isolation coating;
(2) The enteric coating material is prepared into a solution with the mass percentage concentration of 5-20% by using ethanol solution or absolute ethanol with the volume concentration of 60-85% as a third coating solution, and the third enteric coating is obtained by coating and sieving a fluidized bed.
5. The use of a polysaccharide expressed by a strain of bifidobacterium longum according to claim 1, characterized in that: the polysaccharide expressed by the bifidobacterium longum is used for preparing a three-layer coated crystal ball probiotic preparation; the polysaccharide is used for a three-layer coated pellet probiotic preparation, and comprises a first grease coating layer of pellet probiotic pellets, a second isolation coating layer used for coating the probiotic pellets and a third enteric coating layer used for coating the isolation layer from inside to outside; the crystal ball probiotic micro-pellets are prepared from probiotic concentrated solution and/or probiotic powder and food-grade auxiliary materials through extrusion and spheronization;
the first grease coating layer comprises any one or the combination of two of solid palm oil and solid fish oil; the second barrier coating comprises a polysaccharide expressed by a strain of bifidobacterium longum according to claim 1 or a combination of a polysaccharide expressed by a strain of bifidobacterium longum according to claim 1 and pullulan; the third enteric coating is made of enteric materials and comprises one or more of shellac, alcohol-soluble zein, fibroin, acrylic resin and derivatives thereof, cellulose and derivatives thereof, and polyvinyl alcohol derivatives.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310094263.2A CN116478857B (en) | 2023-02-10 | 2023-02-10 | Bifidobacterium longum variant capable of producing polysaccharide and application of polysaccharide in crystal ball probiotic preparation |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310094263.2A CN116478857B (en) | 2023-02-10 | 2023-02-10 | Bifidobacterium longum variant capable of producing polysaccharide and application of polysaccharide in crystal ball probiotic preparation |
Publications (2)
Publication Number | Publication Date |
---|---|
CN116478857A CN116478857A (en) | 2023-07-25 |
CN116478857B true CN116478857B (en) | 2023-12-15 |
Family
ID=87212611
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202310094263.2A Active CN116478857B (en) | 2023-02-10 | 2023-02-10 | Bifidobacterium longum variant capable of producing polysaccharide and application of polysaccharide in crystal ball probiotic preparation |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN116478857B (en) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2010168309A (en) * | 2009-01-22 | 2010-08-05 | Kaneka Corp | Particulate composition and method for producing the same |
CN104894005A (en) * | 2015-04-30 | 2015-09-09 | 江苏紫石微康生物科技有限公司 | Extracellular polysaccharide high-yielding lactic acid bacterium BL21, and preparation method and application thereof |
WO2016200048A1 (en) * | 2015-06-11 | 2016-12-15 | 주식회사 종근당바이오 | Method for increasing survival rate, storage stability, acid resistance or bile resistance of lactic acid bacterium |
WO2017191093A1 (en) * | 2016-05-02 | 2017-11-09 | Lacto Research Sprl | Method for coating microorganisms, powder of said coated microorganisms, and pharmaceutical, nutraceutical, cosmetic, food or sanitary composition comprising said powder |
CN113293113A (en) * | 2021-06-21 | 2021-08-24 | 美益添生物医药(武汉)有限公司 | Bifidobacterium longum MI-186 and application thereof |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050266069A1 (en) * | 2002-09-06 | 2005-12-01 | Simmons Donald L | Stable probiotic microsphere compositions and their methods of preparation |
US20040103821A1 (en) * | 2002-11-29 | 2004-06-03 | Freund Industrial Co., Ltd. | Aqueous shellac coating agent and production process therefor, and coated food and production process therefor, coated drug and production process therefor, glazing composition for oil-based confectionary, glazing process, and glazed oil-based confectionary using same |
CN111134333A (en) * | 2018-11-06 | 2020-05-12 | 内蒙古蒙牛乳业(集团)股份有限公司 | Food or health product containing probiotic microcapsules and preparation method thereof |
-
2023
- 2023-02-10 CN CN202310094263.2A patent/CN116478857B/en active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2010168309A (en) * | 2009-01-22 | 2010-08-05 | Kaneka Corp | Particulate composition and method for producing the same |
CN104894005A (en) * | 2015-04-30 | 2015-09-09 | 江苏紫石微康生物科技有限公司 | Extracellular polysaccharide high-yielding lactic acid bacterium BL21, and preparation method and application thereof |
WO2016200048A1 (en) * | 2015-06-11 | 2016-12-15 | 주식회사 종근당바이오 | Method for increasing survival rate, storage stability, acid resistance or bile resistance of lactic acid bacterium |
WO2017191093A1 (en) * | 2016-05-02 | 2017-11-09 | Lacto Research Sprl | Method for coating microorganisms, powder of said coated microorganisms, and pharmaceutical, nutraceutical, cosmetic, food or sanitary composition comprising said powder |
CN113293113A (en) * | 2021-06-21 | 2021-08-24 | 美益添生物医药(武汉)有限公司 | Bifidobacterium longum MI-186 and application thereof |
Non-Patent Citations (1)
Title |
---|
长双歧杆菌BBMN68寡糖利用预测与验证;欧扬雯珊 等;《中国食品学报》;第20卷(第1期);摘要 * |
Also Published As
Publication number | Publication date |
---|---|
CN116478857A (en) | 2023-07-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN111195266B (en) | Probiotic composition with effect of relieving hyperuricemia and application thereof | |
CN105543126A (en) | Lactobacillus plantarum JM113 and application thereof | |
Wang et al. | Entrapment, survival and release of Bifidobacterium adolescentis within chickpea protein-based microcapsules | |
CN109717481B (en) | Preparation process of coated probiotics | |
JP6456987B2 (en) | Bifidobacterium breve CBT BR3 strain for growth promotion and functional food composition for growth promotion containing the same | |
CN112544977A (en) | Preparation method of multi-layer coated probiotic microcapsule | |
CN111011867B (en) | Probiotic embedded particle and preparation method thereof | |
CN113122466B (en) | Enterococcus faecalis and application thereof | |
CN115851500A (en) | Lactobacillus plantarum and application thereof | |
CN111713685A (en) | Microcapsule wall material and application thereof in preparation of probiotic microcapsules | |
CN107949633B (en) | Lactobacillus rhamnosus, animal feed and composition thereof, and production method of inactive cells | |
CN114806975A (en) | Microecological preparation containing enterogenous probiotics as well as preparation method and application of microecological preparation | |
CN113424965A (en) | Microecological preparation more suitable for yellow population | |
CN116478857B (en) | Bifidobacterium longum variant capable of producing polysaccharide and application of polysaccharide in crystal ball probiotic preparation | |
CN112869172A (en) | Microcapsule wall material with probiotic specificity and preparation method and application thereof | |
CN109602722B (en) | Yeast-coated probiotic microcapsule preparation, preparation method and application thereof | |
CN114806944B (en) | Lactobacillus plantarum LP11, fermentation broth thereof, and preparation method and application thereof | |
CN111264870A (en) | High-environment-resistance probiotic microcapsule and preparation method thereof | |
CN116445327A (en) | Hypolipidemic multielement probiotics and application thereof | |
CN113397170B (en) | Application of marine prebiotics composition for regulating human intestinal flora | |
CN115011508A (en) | High-temperature-resistant enterococcus faecium, high-stability microcapsule preparation thereof and preparation method | |
KR102004204B1 (en) | lactic acid bacteria improved stability and preparing method thereof | |
CN114304688B (en) | Zein coating agent, probiotics preparation coated by coating agent and preparation method thereof | |
CN117487725B (en) | Lactobacillus acidophilus with immunity regulating effect and application thereof | |
CN115058370B (en) | Antioxidant metancholia composite fermentation liquid, preparation method and application |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |